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INTRODUCTION
Hydrogel (also called as aquagel) is a network of polymer chains, three-
dimensional water swollen structures. They are composed mainly by 
hydrophilic homopolymers or copolymers. They swell but are insoluble 
in water, sometimes found as a colloid in which water is the dispersal 
medium. Insolubility is due to chemical or physical cross-links which 
also provide shape. Hydrogels are super permeable (they can contain 
over 99% water) and closely conjure up as natural living tissue due to 
their significant water content, absorbance, and soft texture [1-3].
Since the pioneering work of Wichterle and Lim, 1960, on cross-linked 
2-hydroxyethyl methacrylate (HEMA) hydrogels [4], biomaterial 
scientists have shown deep research interest in hydrogels. In the last few 
years, the smart properties of hydrogel coupled with a high versatility 
and a high tunability of material’s properties lead to innate research 
and management of hydrogels. Polymer hydrogel scaffolds have 
proved to be one of the most efficient matrixes in tissue engineering 
for repairing and regenerating a wide variety of tissues or organs. 
Hydrogels have been used in different biomedical disciplines for over 
50 years. Hydrogel applications range from basic usage as lubricants, 
contact lenses, and burn healing agents to higher performances such 
as controlled drug delivery systems (DDSs) and specialized carriers for 
various macromolecules [5,6].
In late years, extensive efforts have been devoted to fabricating 
hydrogels as novel DDS, since it is a convenient means of site-
specific and time-controlled delivery of therapeutic agents [7,8]. 
Hydrogels have gained considerable interest as drug containers 
or discharge rate controlling barriers [9-14]. Recently developed 
biosensitive hydrogels perform one of the most essential functions 
of drug delivery and biomedical applications, where the kickback 
to external stimuli drives the release of the drugs [1]. New (smart) 
hydrogel systems with various chemically and structurally responsive 
components demonstrate sensitivity to external stimuli including 
temperature, pH, ionic concentration, light, magnetic fields, electrical 
fields, and chemicals. Two or more stimuli-responsive procedures 
have been combined to develop polymers with multiple responsive 
properties. Smart polymer hydrogels change their structural and 
volume phase transition as a response to external stimuli resulting 
in an enormous potential for scientific observations and for various 
advanced technological applications. An innovative approach with the 
production of pH-sensitive hydrogel helped for controlling release 
rates as well as for directing to a site of absorption or action.
Hydrogels have also proved to be an attractive recognition element for 
intelligent DDS, targeted DDS, and microfluidic devices. Bioadhesive 
gels assisted in localizing protein/peptide release systems through oral 
and pulmonary routes, and they consequently grab immense sphere for 
drug targeting and prolonging the drug action at a targeted spot. The 
review is directed toward different structural parameters that impact 
hydrogel fabrication and toward a discussion of the latest developments 
in current research being pushed over hydrogels [1].
TYPES OF HYDROGELS
Hydrogels have been subcategorized based on natural and synthetic 
polymers used for fabrication as shown in Fig. 1.
Natural hydrogels
Collagen, fibrin, gelatin, etc., are the natural polymers used to fabricate 
hydrogels. Natural polymers offer diverse advantageous properties 
such as inherent biocompatibility, biodegradability, and biologically 
recognizable moieties that support cellular activities. However, these 
polymers fail to provide sufficient mechanical properties and may 
contain pathogens or evoke immune/inflammatory response [15,16].
Synthetic hydrogels
Polymers such as polyvinyl alcohol (PVA), polyethylene oxide (PEO), 
and polyacrylic acid (PAA) are examples of synthetic materials used for 
hydrogel fabrication. Précised structures that can be modified to yield 
tailorable degradability and functionality are the exclusive features 
of synthetic polymers. By altering the chemical composition and 
fabrication techniques, the structure of hydrogels can be manipulated. 
Nevertheless, synthetic hydrogels do not possess inherent bioactive 
properties as that of natural polymers [3,16].
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ABSTRACT
Hydrogels are three-dimensional polymeric network, capable of entrapping substantial amounts of fluids. Hydrogels are formed due to physical or 
chemical cross-linking in different synthetic and natural polymers. Recently, hydrogels have been receiving much attention for biomedical applications 
due to their innate structure and compositional similarities to the extracellular matrix. Hydrogels fabricated from naturally derived materials provide 
an advantage for biomedical applications due to their innate cellular interactions and cellular-mediated biodegradation. Synthetic materials have the 
advantage of greater tunability when it comes to the properties of hydrogels. There has been considerable progress in recent years in addressing the 
clinical and pharmacological limitations of hydrogels for biomedical applications. The primary objective of this article is to review the classification 
of hydrogels based on their physical and chemical characteristics. It also reviews the technologies adopted for hydrogel fabrication and the different 
applications of hydrogels in the modern era.
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DIFFERENT METHODS FOR HYDROGEL FABRICATION
Physical methods
Gelation induced through hydrogen bonding, gelation brought by 
sonication, hydrogel formation from polymer solution through ionic 
interactions, heating or cooling of polymer solution, and freeze thawing 
of polymer solution are the various physical methods applicable for 
fabrication of hydrogel. Table 1 depicts the various physical methods to 
synthesize hydrogels.
Chemical methods
The formation of hydrogels through chemical method involves cross-
linking of natural and synthetic polymers. This is achieved through 
the reaction of their functional groups such as OH, COOH, and NH2 
where aldehyde acts as cross-linker (e.g., glutaraldehyde and adipic 
acid dihydrazide). Grafting of monomers on the backbone of the 
polymers or the use of a cross-linking agent to link two polymer chains 
is the elemental chemical cross-linking methods [17]. Table 1 includes 
different chemical methods for hydrogel synthesis.
Cross-linking using high-energy irradiation
Gamma rays as high-energy radiations for polymerizing unsaturated 
compounds electron beams have been widely used. Employing 
irradiation, the conversion of water-soluble polymers can be 
derivatized with vinyl groups to construct hydrogels [18]. A mixture 
of a monofunctional acrylate like acryloyl-l-proline methyl ester in the 
presence of suitable cross-linker can be used to fabricate hydrogels 
by radiation-induced polymerization. Further, cross-linking of various 
polymers such as PVA, poly(ethylene glycol) (PEG), and poly(acrylic 
acid) can be achieved by high-energy irradiation [19]. The properties 
of so-formed gels, such as their swelling and permeability, greatly lean 
on the radiation dose and the concentration of polymer. Free radical 
polymerization of acrylic acid on the backbone of carboxymethyl 
cellulose (CMC) was used to construct hydrogel of CMC. This was done 
by grafting CMC with acrylic acid in the existence of electron beam 
irradiation, in aqueous solution [20].
Enzymatic methods
Cross-linking through enzymatic methods emerged as another 
acceptable method for the construction of hydrogels which helped 
to overcome the limitations raised by physical methods. Hydrogel 
fabrication techniques like cross-linking by radiation-induced 
cytotoxicity in the so-formed gels, whereas cross-linking by physical 
methods produced gels with low mechanical strength and stability. 
Hence, these limitations induced path for cross-linking by naturally 
occurring enzymes [21].
Transglutaminase
Transglutaminase offers a mild alternative to chemical cross-linking. 
Transglutaminase relates to the family of thiol enzymes which induce 
isopeptide bond formation [22]. Gelatin-based hydrogels formed using 
transglutaminase can be employed for incorporation of cells depicting 
good cytocompatibility and attractive features for tissue engineering 
applications [23,24].
Tyrosinase
Tyrosinase-catalyzed hydrogels are mechanically weak and have been 
observed to be formed in the presence of chitosan only. According to 
studies, tyrosinase possesses a feature of fast degradation which makes 
it suitable to be used as glue, wound dressings, and also in protein 
immobilization [25,26].
Phosphopantetheinyl transferase
The use of phosphopantetheinyl transferase for catalyzing hydrogel 
formation from polymers was recently reported [27]. The cross-linking 
catalyzed by phosphopantetheinyl transferase possesses the potential 
to integrate bioactive peptides, specifically the receptor-binding motifs 
for integrin, like RGDs (Arg-Gly-Asp), enabling cell attachment [28].
PROPERTIES OF HYDROGELS
Swelling properties
All polymer chains in hydrogels are deliberated as one molecule when 
cross-linked to each other either physically or chemically regardless of 
its size. The physical texture of the hydrogel can be diversified with a 
slight variation in environmental parameters such as pH, temperature, 
electric signal, and presence of enzymes or other ionic species. Hydrogel 
response fluctuates with the external environmental pH when acidic or 
basic functional groups are cross-linked under the fabrication routine. 
Thus, functional groups dictate swelling profile and degree of ionization 
leading to the shift in volume [29].
Thermoresponsive behavior of the poly(N-isopropylacrylamide) 
(PNIPAM) hydrogel was affected by copolymerization of 
N-isopropylacrylamide (NIPAM) with a hydrophilic monomer N, 
N-dimethylacrylamide (DMAM) and a hydrophobic monomer methyl 
Table 1: Methods for synthesizing physically and chemically cross-linked hydrogels [17]
Physically cross-linked hydrogels Chemically cross-linked hydrogels
Ionic interactions (alginate) Polymerization (acryl group)
Hydrophobic interactions (poly (ethylene oxide)-poly (propylene oxide), poly (ethylene oxide) Radiation (gamma rays)
Hydrogen-bonding interactions (poly (acrylic acid) Small molecule cross-linking (glutaraldehyde)
Stereocomplexation (enantiomeric lactic acid) Polymer-polymer cross-linking (condensation)
Supramolecular chemistry (inclusion complex) Chemically cross-linked hydrogels
Fig. 1: Distinct types of hydrogels based on polymer type
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methacrylate (MMA). NIPAM-DMAM copolymer hydrogel with higher 
lower critical solution temperature (LCST) is more open with water-
swollen behavior above their LCST, and the NIPAM-MMA copolymer 
hydrogels with lower LCST are less open along with water shrunken 
nature below their LCST when compared with PNIPAM homopolymer 
hydrogel [30].
Mechanical properties
The construction of hydrogels should be such that it fulfills the 
mechanical property and retains its physical texture during the 
delivery of therapeutic moieties for the predestined course of time. The 
mechanical properties which are desired in a hydrogel can be achieved 
by altering the degree of cross-linking. The estimation of cross-linking 
density of hydrogels was made possible on the basis of Young modulus 
and Flory’s theory [31]; consequently, the generalized Maxwell model 
helped to control hydrogel linear viscoelastic range along with the 
relaxation spectra [29].
Biocompatible properties
Hydrogels need to be biocompatible and non-toxic in nature for effective 
biomedical applications. Biocompatibility of hydrogels dwells in two 
basic aspects. First, biosafety includes the exemption of cytotoxicity, 
mutagenesis, and carcinogenesis, and second, biofunctionality, i.e., 
the capability of material to execute the distinct task for which it is 
intended. The presence of synthetic cross-linkers and initiators used in 
the polymerizations of naturally derived monomers and prepolymers are 
subjugated to the same toxicity concerns as purely synthetic hydrogels; 
therefore, natural polymers are frequently regarded to have superior 
biocompatibility over synthetic ones [29].
APPLICATIONS OF HYDROGELS
Drug delivery
Hydrogels have played an efficient role as DDS since they possess 
advantageous properties such as excellent tissue compatibility, easy 
manipulation, and solute permeability [32]. Since decades, hydrogels 
have been utilized for the fabrication of DDS. In the aqueous medium, 
the drug enclosed within the hydrogel dissolves as soon as the water 
penetrates into the system. Drug within the hydrogel diffuses out in 
the surrounding aqueous medium by means of diffusion [33]. Smart 
polymeric hydrogels deliver drugs at the right time and accurate 
concentration in response to external stimulus [34].
Active molecules of a drug contain a broad spectrum of proteins and 
peptides, which are released through hydrogel carriers as they bind less 
strongly with the drugs. The release of drugs in the body at distinct sites 
and times would reduce unwanted side effects, eventually improving 
the medical treatment [35].
Smart hydrogels (Fig. 2) change their properties when in contact 
with distinct stimuli for controlling drug delivery. Drug release 
profiles under temperature responsive hydrogel display a stepwise 
temperature change, thus being extremely studied to obtain an “on-off” 
profile [35]. At the molecular level, the physical and chemical properties 
such as permeability, enviro-responsive nature, surface functionality, 
biodegradability, and surface biorecognition sites were optimized by 
the researchers for controlled drug delivery applications [7]. Drug 
incorporation, release of model molecules, and release kinetics are the 
factors which are taken into consideration while fabricating a hydrogel 
for drug delivery.
Drug incorporation
Ligands which are metabolically cleavable and have specific affinity 
for active agents are used to perform drug loading by physical 
entrapment, with either post-fabrication drug absorption or sometimes 
in situ encapsulation. Materials employed as hydrogel carriers for 
osteoinductive factors include alginate, gelatin, hyaluronic acid (HA), 
and synthetic or natural PEG-based polymers. Drug loading just before 
cross-linking helps to maintain its stability as well as its biological 
potency. Thus, during the fabrication process, this prevents the drug 
from exposure to rough fabrication conditions or from leaching 
out  [36].
Release of model molecules
Biomolecule release occurs by the process of diffusion of molecules 
acting as a function of porosity, degradation, or swelling of hydrogels. 
Physical cross-linking through ultraviolet radiation or thermal 
and ionic or covalent cross-linking (by acrylate or thiol chemistry, 
glutaraldehyde or carbodiimide, etc.) methods can be employed to 
estimate the permeability and the swelling of hydrogel for release 
of model molecule  [37]. Cytocompatibility and also the effective 
control over small-sized biomolecules and proteins are decreased by 
enhanced cross-linking of polymers. Chemically-controlled delivery of 
growth factors is the most efficient system for providing reproducible 
release profiles from hydrogels, where it usually gets affected by mode 
and degradation rate of hydrogel, interactions between hydrogel 
and molecule, and also by the inclusion of varied phases (including 
polymers or even particulate carriers) or of cleavable sequences in 
the hydrogel network [38]. Hydrogels bearing cross-linkable labile 
ester bonds can be produced by copolymerizing PEG with chemical 
Fig. 2: Design concept for “Smart” drug delivery systems with sensor, processor, and effector functions
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intermediaries which have either end-capped acrylate or the sebacic 
acid acrylate group or either by PLA or poly(gamma-glutamic acid) 
(PGA). Lyophilizing silk hydrogel loaded with antibody was employed 
to produce sustained delivery matrix called lyogels focusing over the 
interactions occurring between antibodies and its feasibility as a potent 
delivery system for the therapeutic protein [36].
Kinetics of drug release from hydrogels
In DDS, drugs can be encased or immersed within a hydrogel 
corresponding to several diverse types of controlled release systems. 
Further, controlled release systems were subcategorized into diffusion-
controlled systems and swelling-controlled systems [39].
Diffusion-controlled delivery systems are subdivided into reservoir 
devices and matrix devices. Diffusion is the key phenomena for release 
of the drugs in both the cases. A reservoir delivery system usually 
consists of capsules, cylinders, spheres, or slabs where drug core 
is enclosed within a hydrogel membrane. The drug concentration 
difference must remain constant for the sake of uniform release rate.
In matrix systems, the drug is fully dispersed all through the three-
dimensional structure of the hydrogel. Constituents required for the 
construction of matrix tablets include a compression of a mixture 
of drug and polymer powders. Considering the release profiles, 
macromolecular mesh or water-filled pores are responsible for drug 
release throughout the matrix. The release pace is proportional to the 
square root of time in preference to the constant time-independent rate 
available with reservoir systems [40].
The drug is dispersed within a glassy polymer as a matrix device in 
swelling-controlled release systems. The polymer begins to swell as 
it comes in unity with water or another biofluid. The drug can now 
diffuse out of the swollen rubbery area of the polymer as the glass 
transition temperature of the polymer is lowered allowing a relaxation 
of molecular chains [41]. In some cases, anomalous transport occurs 
which is the combination of swelling-controlled release as well as 
diffusion [39].
Wound healing and wound dressing
Hydrogels have the ability to absorb and retain foreign bodies such 
as bacteria in its network structure. Thus, it can act as a moist wound 
dressing material. In further applications, hydrogels have the tendency 
to adsorb and eliminate dead tissues which prove to be a novel 
feature for defending wounds. It also helps in enhancing fibroblast 
proliferation by reducing fluid loss from the wound surface  –[33]. 
Hydrogels lack mechanical strength but fulfill all the criteria to be used 
as an outstanding wound dressing material. Permeability, flexibility, and 
occlusive properties gradually depend on the swelling characteristics of 
various engineered hydrogels. The first hydrogel-based wound dressing 
material formulated was hydron [42-45]. Some other examples of 
dressings prepared from HEMA monomers in combination with other 
polymers such as PEG, acrylamide, or agar are Gel perm, Intrasite, 
Biolex, and Vigilon [46,47].
Tissue engineering
Hydrogels likely resemble natural tissues thus emerged as one of the 
abundantly used scaffold biomaterials [35]. Tissue engineering has 
received increased focus in recent decades due to the use of resorbable 
hydrogels. This is since the properties of a hydrogel can be modified 
effortlessly. Tissue engineering involves both synthetic and natural 
polymer hydrogels to restore cartilage, tendon, ligament, skin, blood 
vessels, and heart valves [48]. Naturally derived hydrogels comprise 
collagen, silk, keratin, agarose, fibrin, alginate, chitosan, gelatin, and 
HA, whereas the synthetic hydrogels include polyurethanes, PEO, PVA, 
PAAc, and poly (propylene fumarate-co-ethylene glycol) [35,49,50].
Hydrogels also act as an immune isolation barrier for 
microencapsulation technology [51] along with acting as a scaffold for 
tissue engineering  [52]. Microencapsulation involves a process where 
allogeneic or xenogeneic cells are harbored from the host’s immune 
system using a semipermeable membrane. In hydrogels, polymeric 
microcapsules containing cells are enclosed in such a way to intensify 
the functionality of transplanted constructs [51]. Hydrogels act as 
support structures for cell growth and function and deliver signals to 
cells [53,54].
To construct injectable thermoresponsive hydrogels, thermoresponsive 
polymers are mixed at room temperature with the cells, thus optimized 
to be used as substrates that facilitate cell growth and proliferation and 
then be injected into the body. The polymer forms a physical gel as the 
temperature increases (to 37°C) which is quite above the polymer’s LCST 
on injection. The cells are encapsulated within the three-dimensional 
structure of the gel [34]. Three-dimensional corneal implant, tracheal 
gland cells, etc., are examples of collagen-coated tissue culture inserts. 
Type III collagen mixed with fibronectin or with matrigel is frequently 
used for culturing normal mature liver cells which also involve fibrillar 
collagen-coated scaffolds (e.g., filter, swatch of nylon, transwell, and 
biodegradable microcarrier) [55].
Biocompatible/biodegradable materials along with other hydrogels 
were found to expand in contact with liquid when coated over nails, 
screws, pins, hip and knee replacements, etc., in the case of orthopedic 
fasteners and replacements. In some approaches, replacements made 
up of stainless steel, metal alloys, titanium, or cobalt chromium, coated 
along hydrogels proved to be a vital step in improving metal-polymer 
adhesion. Natural or synthetic polymers are raised as constructs for 
replacement of cartilage, where hydrogel phase often serves as carrier 
for cells and therapeutics. Hydrogels resemble cartilage tissues as 
they possess high water content that ranges between 75% and 80% 
by weight [56]. This helps in rapid diffusion of soluble nutrients and 
supports to retain rounded cell morphologies [57,58]. Injectable 
solutions are widely accepted as constructs which are delivered by 
invasive process [59,60]. PEG-based hydrogel/calcium phosphate 
nanocomposite developed by Schlichting ., 2011 [60], emerged as 
useful temporary reinforcement to fill cracks in cartilage occurred by 
trauma [61]. To mechanically stabilize the severely injured cartilage 
and prevent further damage to the cartilage (which occurs during the 
following 1–2 weeks after the injury), the photopolymerizing copolymer 
solution was introduced under this area [61].
Gene delivery
Gene therapy is the delivery of desired therapeutic genes into cells 
aiming repair, replacement, and regulation of defective genes to 
avoid diseases [34]. Poly-L-lysine, PEG, polyamidoamine dendrimer, 
polyethylenimine, PGA, poly(lactic acid) (PLA), and poly(di-lactic acid-
co-glycolic acid) (PLGA) are examples of polymers used by scientists for 
gene delivery [61]. Researchers have used PEG-PLGA-PEG hydrogel for 
delivery of plasmid-beta 1 gene in diabetic mouse model that enhanced 
wound healing [62]. Transfection is a process of gene delivery by 
polymeric carriers that involve first, complexation of DNA and polymer, 
addition of DNA/polymer complex into cells for a period. Elimination of 
end complexes from the cells and last, incubation time where cells are 
kept incubating for a period till the results are recorded.
Cancer therapy
Hydrogel microparticles have the ability to extend and target drugs, 
which reduce the body’s burden remarkably [63]. Since faster and 
greater swelling is needed, superporous hydrogels will be more useful 
than normal hydrogels. For direct administration, such as in the case 
of intratumoral administration, hydrogels can be directly transplanted 
or injected into the tumor. This increases the efficacy of the anticancer 
agent. Hydrogel implantation can be used as an alternative approach 
for multiple dose conventional therapies [1].
Thermoresponsive hydrogels have been reported as delivery systems 
for chemotherapeutic agents because they can be injected as a liquid 
into the tumor and then gelled at body temperature. OncoGelTM is an 
example of an anticancer drug-loaded thermoresponsive hydrogel 
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which is intended for the localized delivery of paclitaxel into the tumor 
minimizing significantly the side effects associated with conventional 
administration of the drug. The benefits of OncoGelTM include direct 
deposition of the formulation in the targeted site using a syringe in case 
of superficially accessible tumors or more specialized tools for deeper 
solid tumors. [64,65]. Magnetic hydrogel nanocomposites (NCs) are a 
new emerging class of stimuli-responsive hydrogels being developed 
for in vivo drug release for tumor therapy. Incorporation of magnetic 
nanoparticles such as iron oxide (Fe3O4) in a hydrogel matrix results in 
a tunable NC that can be distantly controlled by a magnetic field [66].
Diagnostics
Hydrogels serve as carriers with engineered release properties, as 
coatings with targeting capabilities, as coatings with stealth properties 
or combinations, and as whole, therefore, researchers introduced 
hydrogel systems in imaging applications [7]. For example, intracellular 
imaging pertains a novel carrier for quantum dots based on 
nanogels  [67]. In addition, radioisotopes for radiation delivery devices 
were in capsulated by hydrogel coatings [68,69].
Microarray technology
A variety of applications that enclose hydrophilic polymers requires 
control of surface properties and spatial location. Hydrogels along 
with hydrophilic polymers have been designed for controlling cell-cell 
interactions, altering surfaces, immobilizing cells, and protein within 
hydrogel microstructures for usage in microarray. Thus, to immobilize 
cells in particular regions of a substrate, photocrosslinkable PEG 
hydrogels have been used. This task can be performed by patterning PEG 
on a substrate [70,72]. Collagen gels have also been molded to pattern 
cells [73]. Polysaccharides being one of the natural hydrophilic polymers 
were broadly used as patterning materials. As per one of the studies, 
hydrophilic polysaccharides such as HA possess the tendency to form 
adsorbed monolayers on surfaces of hydrophilic substrates  [74,75].
Medical and biological sensors
Hydrogels can be incorporated with biosensors where the constructed 
gel expands or contracts in response to actions delivered by the specified 
substance or condition. Ultrasensitive bio-microelectromechanical 
systems (MEMSs) sensor platform was designed and tailored over 
silicon microcantilevers with the help of environmentally responsive 
hydrogel [76,77]. Microscale MEMS sensor device was the first, where 
actuation was controlled by an intelligent polymer network [7]. A hydrogel-
based photonic crystal was designed by Holtz and Asher as glucose sensor 
that sensed glucose in patients suffering from diabetes mellitus [78]. Table 
2 depicts the recent applications of hydrogels for biosensors.
Ophthalmology
Most of the ophthalmic drugs on an average constitute eye drops or 
eye ointments. These drugs face certain drawbacks and, hence, fail to 
deliver drugs efficaciously to the intraocular tissue [79]. On the other 
hand, corneal tissue irritation is one of the familiar problems raised 
by eye ointments [80]. Therefore, exploring alternate drug delivery 
strategy helps to overcome these drawbacks by exploring particles, 
films, hydrogels, and contact lenses [81].
Hydrogels being the principal material for soft contact lenses emerged 
as one of the most potent drug carriers for ophthalmic drugs because 
of their high water content [82,83]. Hydrogel lenses are dipped 
into drug solution for effective drug loading [84,85]. Conventional 
HEMA-based hydrogel lenses have been diagnosed for ophthalmic 
drug [82,86]. Under one of the approaches, HEMA-based hydrogels 
copolymerized with methacrylic acid were diagnosed for the release 
of timolol, a therapeutic drug in the treatment of glaucoma. Bausch 
and Lomb, in 1999, introduced the first silicone hydrogel lens in the 
market by the name PureVision. Silicon-based SCLs were developed to 
increase oxygen permeability. Since 1970, silicon elastomers pertaining 
high oxygen permeability have been in trend as a key material for 
contact lenses. Various other experimental approaches under contact 
lenses were investigated to raise the loading efficiency that embraces 
embedding drug-loaded nanoparticles, microemulsions, or liposomes 
in the hydrogel lens [87-90].
Neural therapy
In human physiology, the central nervous system (CNS) possesses 
limited intrinsic regenerative capacity. Hence, various therapies fail to 
provide significant functional recovery in diseases and injuries of the 
CNS including those in the brain, spinal cord, and retina. Diffusion of 
molecules into the brain by traditional oral or intravenous routes has 
always been one of the challenges, as delivery of these therapies to the 
CNS is interrupted by blood–brain barriers. Injectable hydrogels thus 
provide a nominal invasive, localized, and void-filling platform for drug 
delivery to the CNS [91].
In other popular approach, liposomes and lipid microtubules [92,93] 
or polymeric microspheres [94,95] were combined with hydrogel 
for drug delivery methods. Drug delivery to CNS in context to 
hydrophobic liposomes or microspheres yielded extended release 
times for hydrophilic molecules [96]. Extracellular matrix of 
connective, epithelial, and neural tissues is highly loaded with HA, 
thus making it widely used material for tissue regeneration. HA 
interacts with cells principally through CD44 and receptor for HA-
mediated motility surface receptors  [97,98] and also plays key roles 
in various metabolic and cellular processes such as cell proliferation, 
morphogenesis, inflammation, and wound repair. PNIPAAm is also 
being commonly used as a temperature responsive DDS [99,100] and 
PLA as micro/nanoparticles DDSs are the widely studied hydrogels by 
the researchers [101].
Immunoisolation
Immunoisolation simply deals with encapsulating a living cell within 
a semipermeable barrier that permits the bidirectional passage of 
gases and metabolites but regulating the entry of large molecules and 
immunoglobulin. Immunoisolation mechanically chunks the entry 
of immunocytes which help to swamp the limitations of implanting 
free cells [102]. Based on the basis of immune isolation and immune 
protection, Chang, 1964, was the first to construct a bioartificial 
organ using hydrogel. Immunoisolation of transplanted cells secreting 
hormones, neurotransmitters, growth factor, and other bioactive 
cellular secretary products has raised the advancement of various gel 
devices for wider purposes [103].
CONCLUSION
Recently, many hydrogel-based networks have been designed and 
tailored to meet the needs for different biomedical applications. 
Considerable progress has been made in improving the properties 
of hydrogels used for drug delivery, expanding the range of drugs 
and kinetics which can be achieved using hydrogel-based delivery 
vehicles. However, numerous challenges remain to enhance the 
clinical applicability of hydrogels as drug carriers. There is a need 
for continued improvement in delivery of more sensitive molecules 
such as proteins, antibodies, or nucleic acid which can easily unfold 
itself by the interaction with the hydrogel delivery vehicle. Hydrogel 
delivery systems can leverage therapeutically beneficial outcomes of 
drug delivery and have found clinical use. Hydrogel can provide spatial 
and temporal control over the release of various therapeutic agents 
including small molecule drugs, macromolecules drugs, and cells. 
Table 2: Recent developments in hydrogel-based 
biosensors [76-78]
Stimulus Hydrogel Application Output signal
Glucose PA-PEG Glucose 
biosensor
Optical, color
Protein PNIPAm-co-AAc Antibiotin 
biosensor
Optical, focusing




PEG: Poly (ethylene glycol)
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Due to the tunable physical properties, controllable degradability and 
capability to protect labile drugs from degradation, hydrogel serves as 
a platform on which various encapsulated drugs occur to control drug 
release. Self-assembled hydrogel and hydrogels for tumor targeting 
and imaging are to be explored at a greater pace. The valuable addition 
of efficient DDS in comparison to the newly found drug can benefit 
economically as well as drastically reduce the duration of time taken to 
develop the new drug.
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